Biomark Diagnostics Inc. (FRA:20B)

Biomark Diagnostics Revenue

In the fiscal year ending March 31, 2026, Biomark Diagnostics had annual revenue of 59.79K CAD, down -61.23%. Biomark Diagnostics had revenue of 7.01K in the quarter ending March 31, 2026, a decrease of -82.03%.

• Revenue: 59.79K CAD
• Revenue Growth: -61.23%
• P/S Ratio: 819.81
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 30.45M EUR

Revenue Chart

Chart

Chart

* This company reports financials in CAD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	59.79K	-94.43K	-61.23%
Mar 31, 2025	154.22K	-9.00K	-5.52%
Mar 31, 2024	163.22K	9.73K	6.34%
Mar 31, 2023	153.49K	109.56K	249.38%
Mar 31, 2022	43.93K	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 23, 2026

Data Sources Report a data error